↓ Skip to main content

The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin

Overview of attention for article published in Cardiovascular Diabetology, July 2021
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
176 Dimensions

Readers on

mendeley
122 Mendeley